Human medicines European public assessment report (EPAR): Vocabria, cabotegravir, Date of authorisation: 17/12/2020, Revision: 18, Status: Authorised

Human medicines European public assessment report (EPAR): Sitagliptin SUN, sitagliptin fumarate, Date of authorisation: 09/12/2021, Revision: 4, Status: Authorised

Human medicines European public assessment report (EPAR): Brimica Genuair, aclidinium,formoterol fumarate dihydrate, Date of authorisation: 19/11/2014, Revision: 17, Status: Authorised

Human medicines European public assessment report (EPAR): Bretaris Genuair, aclidinium bromide, Date of authorisation: 20/07/2012, Revision: 21, Status: Authorised

Human medicines European public assessment report (EPAR): Glivec, imatinib, Date of authorisation: 07/11/2001, Revision: 52, Status: Authorised

Opinion/decision on a Paediatric investigation plan (PIP): Vafseo, vadadustat, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Blood and lymphatic system disorders, PIP number: EMA/PE/0000245403

EMA/PE/0000183673

Expert panel support for orphan medical devices

Scientific advice for high-risk medical devices

Opinion/decision on a Paediatric investigation plan (PIP): Voxzogo, vosoritide, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Congenital, familial and genetic disorders, PIP number: EMA/PE/0000235382